| Product Code: ETC13296384 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Cannabis Pharmaceuticals Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Cannabis Pharmaceuticals Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Cannabis Pharmaceuticals Market Revenues & Volume, 2021 & 2031F |
3.3 North America Cannabis Pharmaceuticals Market - Industry Life Cycle |
3.4 North America Cannabis Pharmaceuticals Market - Porter's Five Forces |
3.5 North America Cannabis Pharmaceuticals Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Cannabis Pharmaceuticals Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 North America Cannabis Pharmaceuticals Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 North America Cannabis Pharmaceuticals Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 North America Cannabis Pharmaceuticals Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.10 North America Cannabis Pharmaceuticals Market Revenues & Volume Share, By Benefit, 2021 & 2031F |
4 North America Cannabis Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Cannabis Pharmaceuticals Market Trends |
6 North America Cannabis Pharmaceuticals Market, 2021 - 2031 |
6.1 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Capsules, 2021 - 2031 |
6.1.3 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Oils, 2021 - 2031 |
6.1.4 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Topicals, 2021 - 2031 |
6.2 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Pain Management, 2021 - 2031 |
6.2.3 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Anxiety Relief, 2021 - 2031 |
6.2.4 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Skin Conditions, 2021 - 2031 |
6.3 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Patients, 2021 - 2031 |
6.3.3 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.4 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Source, 2021 - 2031 |
6.4.2 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Cannabis-Based, 2021 - 2031 |
6.4.3 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Hemp-Based, 2021 - 2031 |
6.4.4 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Plant-Based, 2020 - 2028 |
6.5 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Benefit, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Non-Psychoactive, 2020 - 2028 |
6.5.3 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Natural, 2020 - 2028 |
6.5.4 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Anti-Inflammatory, 2020 - 2028 |
7 North America Cannabis Pharmaceuticals Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.1 United States (US) Cannabis Pharmaceuticals Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.2 Canada Cannabis Pharmaceuticals Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.3 Rest of North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3 North America Cannabis Pharmaceuticals Market Revenues & Volume Share, By Application, 2021 & 2031F |
7.3.1 United States (US) Cannabis Pharmaceuticals Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.2 Canada Cannabis Pharmaceuticals Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.3 Rest of North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United States (US) Cannabis Pharmaceuticals Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Canada Cannabis Pharmaceuticals Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 Rest of North America Cannabis Pharmaceuticals Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Source, 2021 - 2031 |
7.5.1 United States (US) Cannabis Pharmaceuticals Market, Revenues & Volume, By Source, 2021 - 2031 |
7.5.2 Canada Cannabis Pharmaceuticals Market, Revenues & Volume, By Source, 2021 - 2031 |
7.5.3 Rest of North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Source, 2021 - 2031 |
7.6 North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Benefit, 2021 - 2031 |
7.6.1 United States (US) Cannabis Pharmaceuticals Market, Revenues & Volume, By Benefit, 2021 - 2031 |
7.6.2 Canada Cannabis Pharmaceuticals Market, Revenues & Volume, By Benefit, 2021 - 2031 |
7.6.3 Rest of North America Cannabis Pharmaceuticals Market, Revenues & Volume, By Benefit, 2021 - 2031 |
8 North America Cannabis Pharmaceuticals Market Key Performance Indicators |
9 North America Cannabis Pharmaceuticals Market - Export/Import By Countries Assessment |
10 North America Cannabis Pharmaceuticals Market - Opportunity Assessment |
10.1 North America Cannabis Pharmaceuticals Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Cannabis Pharmaceuticals Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.3 North America Cannabis Pharmaceuticals Market Opportunity Assessment, By Application, 2021 & 2031F |
10.4 North America Cannabis Pharmaceuticals Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 North America Cannabis Pharmaceuticals Market Opportunity Assessment, By Source, 2021 & 2031F |
10.6 North America Cannabis Pharmaceuticals Market Opportunity Assessment, By Benefit, 2021 & 2031F |
11 North America Cannabis Pharmaceuticals Market - Competitive Landscape |
11.1 North America Cannabis Pharmaceuticals Market Revenue Share, By Companies, 2022 |
11.2 North America Cannabis Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here